RNAZ Dividend History - Transcode Therapeutics

Currently (January 2025) Transcode Therapeutics Inc does not pay a dividend.

As of January 2025, Transcode Therapeutics (RNAZ) does not pay a dividend.
Top Dividend Payers in Biotechnology
Top Dividend Yield
Symbol Market Cap in USD Yield Yield on Cost
RNAZ 2m - -
ORKA 888m 102% 49.1%
ABBV 303,294m 4.39% 11.0%
LENZ 600m 3.91% 8.23%
Top Dividend Grower
Symbol Market Cap in USD Grow Rating
RNAZ 2m - -
BIM 12,387m 34.9% 56.8%
ABBV 303,294m 5.61% 77.2%
AMGN 143,253m 7.06% 69.3%

RNAZ Dividend History

No dividends paid yet.

RNAZ Dividend History - FAQ

What is the Dividend Yield of RNAZ?

As of January 2025 RNAZ`s Dividend Yield is 0.00%. It is calculated by dividing the dividend payments of the last 12-Months (TTM) of by the current stock price of 3.43.

What is the long-term Dividend Growth Rate of RNAZ?

In the last 5 Years the Average Dividend Growth Rate was % per year. This shows that the dividend payments have been stable over time. It is a neutral sign, as it indicates that the dividend payments have been stable over time.

How often does RNAZ pay dividends?

Within the last 12 Months (TTM, Trailing Twelve Months) RNAZ paid 0 times a dividend.

What is the Yield on Cost of RNAZ?

The 5 Year Yield-On-Cost is %. That's the effective dividend income you'd receive today if you purchased Transcode Therapeutics five years ago. It is calculated by the Rate of the last 12 Months () divided by the price 5 years ago (105600.00).

What is the Payout Consistency of RNAZ?

RNAZ has a Payout Consistency of 0.0%. It shows how stable (Values above 85%) or unstable (Values below 65%) the dividend payouts have been over time. Cutting a dividend is considered negative, while increasing it is considered positive. Equally paying dividends is considered moderate positive.

What is the Dividend Rating of RNAZ?

The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to 100. Ratings surpassing 60 are regarded as favorable, exceeding 75 are strong, and surpassing 85 are exceptional. The calculations includes: Yield, Yield on Cost, Dividend History, Consistency of Payouts and Growth Rates over time.

Does RNAZ have a good Dividend Yield?

RNAZ`s 0.00% Dividend Yield is considered as: unknown.
A good Dividend Yield is generally considered to be at least 4%, while a high dividend yield is considered to be anything over 6%.

What is the next Dividend Date for RNAZ?

The next Dividend Date for RNAZ is unknown.

What is the Dividend Payout Ratio of RNAZ?

The Dividend Payout Ratio of RNAZ is unknown. A lower payout ratio, such as 30-60%, means there's more room for dividends to grow and better protection to pay dividends even in a recession. If it’s over 80-90%, it could be a red flag that dividends might not be sustainable. However, certain sectors have exceptions due to regulatory requirements or industry norms. For example, REITs and BDCs are required by law to distribute 90% or more of their taxable income as dividends, making high payout ratios standard. Banks, on the other hand, often maintain moderate payout ratios (40-60%) to comply with regulatory capital requirements and ensure stability. If companies outside these regulated sectors have payout ratios exceeding 80-90%, it could be a red flag for unsustainable dividends.

Bonus Section: RNAZ Outstanding Shares

What is the Trend of RNAZ`s Outstanding Shares?

The Outstanding Shares of Transcode Therapeutics are growing at a rate of 349.53% per year on average over the last 5 years. The Correlation Coefficent of the Outstanding Shares is 100.0%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Transcode Therapeutics ever had a Stock Split?

Yes, last Stock Split was on 2024-12-04 with a factor of 1:33. This reverse stock split decreased the number of shares and increased the price per share by a ratio of 0.03.
Year Number of Shares (Mill.) Growth Rate
2020 8000
2021 16100 +101.25%
2022 16200 +0.62%
2023 627400 +3772.84%
2024 14685000 +2240.61%